Calcifediol Monohydrate Market, By Application (Animal Feed and Pharmaceutical), and Geography (North America, Europe, Asia Pacific and Rest of the World) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
|発行||AnalystView Market Insights||商品コード||874733|
|出版日||ページ情報||英文 181 Pages
|カルシフェジオール水和物の世界市場：市場分析・シェア・傾向・規模・予測 Calcifediol Monohydrate Market, By Application (Animal Feed and Pharmaceutical), and Geography (North America, Europe, Asia Pacific and Rest of the World) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025|
|出版日: 2019年06月01日||ページ情報: 英文 181 Pages||
The calcifediol monohydrate acid was valued at USD 31,800 thousand by 2017, growing with 5.4% CAGR during the forecast period, 2018-2025.
Calcifediol monohydrate (25-Hydroxyvitamin D3) is a prehormone or vitamin D3 analogue, which is produced by hydroxylation of vitamin D3 (cholecalciferol) through the utilization of enzyme cholecalciferol 25-hydroxylase. Rising spending on Advanced Pharmaceutical Ingredients (API) manufacturing in the emrging economies including, China and India is projected to remain a favorable factor for the Calcifediol monohydrate market. For instance, investment in production of vitamin D analogues is likely to remain a key trend on account of their increasing visibility as an ingredient with good gene regulatory properties. For instance, Dishman Group owned a vitamin D analogue manufacturing facility in the Netherlands in 2017. The company is planning to expand the production capacity of vitamin D analogues including, calcifediol monohydrate in India in order to cater the growing demand from animal feed and pharma sectors.
Furthermore, rising prevalance of chronic kidney disese (CKD) on a global level as a result of fluctuating diet patterns and hectic workstyle is driving the growth of calcifediol monohydrate-based drugs. For instance, according to National Center for Chronic Disease Prevention and Health Promotion (USA), around 15% of the total U.S. population is suffering from chronic kidney disease (CKD).
In addition, rising prevalence of rickets and osteomalacia is expected to provide growth opportunity for this industry. For instance, according to The Centers for Disease Control and Prevention, 5 per 1,000,000 children aged between 6 months and 5 years have rickets. On contrary, the production of this chemical involves technological advanced machinery owing to its high concentration and purity of vitamin D, hampering the market growth to some extent.
Global calcifediol monohydrate market is segmented on the basis of three application segments including, animal feed, pharmaceutical, and others. Others application segment covers the use of calcifediol monohydrate in personal care and nutraceutical applications. Among animal industry, species such as broilers, cattle, breeders, and swine are expected to use calcifediol monohydrate as a key source for the calcium and phosphorus absorption in the body and mobilisation of calcium in bones. In addition, it also helps in improving the immune cells.
Asia Pacific is accounted for the largest market, accounting for over 50% of global calcifediol monohydrate market. In the region, animal feed accounted for 95% of the produced volume of calcifediol monohydrate. Increasing production of livestock in the region is expected to fuel the demand for animal feed. Europe is considered to be the second largest consumer of calcifediol monohydrate. The region is expected to witness a high growth rate on account of rising prevalence of kidney disorders.
Companies are actively engaged in research and development activities. Major manufacturers of vitamin D and vitamin D2 including Chemvon Biotechnology, and Dishman Group owned technology to produce the calcifediol. In addition, it is noted that key manufacturers are installing their manufacturing facilities in the Europe due to the favorable regulations regarding manufacturing and marketing of Vitamin D analogues and Vitamin D3 APIs.
The market size and forecast for each segment and sub-segments has been considered as below:
The scope of this report covers the market by its major segments, which include as follows: